EC Number   |
Specific Activity Minimum [µmol/min/mg] |
Specific Activity Maximum [µmol/min/mg] |
Reference |
|---|
  4.1.3.41 | 0.36 |
- |
after 50fold purification, using DL-threo-3-hydroxyaspartate as substrate, in 0.02 mM HEPES buffer, pH 8.0, at 30°C |
649407 |
| 4.1.3.41 | 0.6 |
- |
crude extract, in 0.02 mM HEPES buffer, pH 8.0, at 30°C |
649407 |
| 4.1.3.41 | 14.6 |
- |
after 50fold purification, using D-threo-3-3,4-methylenedioxyphenylserine as substrate, in 0.02 mM HEPES buffer, pH 8.0, at 30°C |
649407 |
| 4.1.3.41 | 17.5 |
- |
after 50fold purification, using D-erythro-3-3,4-methylenedioxyphenylserine as substrate, in 0.02 mM HEPES buffer, pH 8.0, at 30°C |
649407 |
| 4.1.3.41 | 20 |
- |
after 50fold purification, using D-threonine as substrate, in 0.02 mM HEPES buffer, pH 8.0, at 30°C |
649407 |
| 4.1.3.41 | 25 |
- |
after 50fold purification, using D-allo-threonine as substrate, in 0.02 mM HEPES buffer, pH 8.0, at 30°C |
649407 |
| 4.1.3.41 | 30 |
- |
after 50fold purification, using D-erythro-3-hydroxyaspartate as substrate, in 0.02 mM HEPES buffer, pH 8.0, at 30°C |
649407 |
| 4.1.3.41 | 95 |
- |
after 50fold purification, using D-threo-3-phenylserine as substrate, in 0.02 mM HEPES buffer, pH 8.0, at 30°C |
649407 |
| 4.1.3.41 | 99 |
- |
after 50fold purification, using D-erythro-3-phenylserine as substrate, in 0.02 mM HEPES buffer, pH 8.0, at 30°C |
649407 |
